UB Paderborn / Katalog / Suche / in CDI

Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

Journal of Virology, 2011-04, Vol.85 (7), p.3128-3141

2011

Volltextzugriff (PDF)

The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection

Journal of Virology, 2004-05, Vol.78 (10), p.5205-5215

2004

Volltextzugriff (PDF)

Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes

Scientific reports, 2021-09, Vol.11 (1), p.19546-19546, Article 19546

2021

Volltextzugriff (PDF)

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

Journal of clinical microbiology, 2018-12, Vol.56 (12)

2018

Volltextzugriff (PDF)

Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

Journal of Virology, 2002-09, Vol.76 (18), p.9035-9045

2002

Volltextzugriff (PDF)

Characterization of Structural Features and Diversity of Variable-Region Determinants of Related Quaternary Epitopes Recognized by Human and Rhesus Macaque Monoclonal Antibodies Possessing Unusually Potent Neutralizing Activities

Journal of Virology, 2011-10, Vol.85 (20), p.10730-10740

2011

Volltextzugriff (PDF)

Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activity Is Usually Restricted by Epitope Masking

Journal of Virology, 2005-01, Vol.79 (2), p.780-790

2005

Volltextzugriff (PDF)

Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study

The Journal of infectious diseases, 2021-10, Vol.224 (8), p.1345-1356

2021

Volltextzugriff (PDF)

Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry

Tuberculosis (Edinburgh, Scotland), 2018-07, Vol.111, p.178-187

2018

Volltextzugriff (PDF)

The C108g Epitope in the V2 Domain of gp120 Functions as a Potent Neutralization Target When Introduced into Envelope Proteins Derived from Human Immunodeficiency Virus Type 1 Primary Isolates

Journal of Virology, 2005-06, Vol.79 (11), p.6909-6917

2005

Volltextzugriff (PDF)

Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes

Scientific reports, 2020-08, Vol.10 (1), p.13944-13944, Article 13944

2020

Volltextzugriff (PDF)

Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci

The Journal of immunology (1950), 2002-07, Vol.169 (1), p.595-605

2002

Volltextzugriff (PDF)

V3-Specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1

AIDS research and human retroviruses, 2001-12, Vol.17 (18), p.1737-1748

2001

Volltextzugriff (PDF)

Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site

Journal of Virology, 1996-07, Vol.70 (7), p.4466-4473

1996

Volltextzugriff (PDF)

Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites

Journal of Virology, 1993-09, Vol.67 (9), p.5692-5697

1993

Volltextzugriff (PDF)

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120

AIDS research and human retroviruses, 1992-04, Vol.8 (4), p.461-467

1992

Volltextzugriff (PDF)

A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody

Journal of Virology, 1994-07, Vol.68 (7), p.4636-4642

1994

Volltextzugriff (PDF)

A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates

AIDS research and human retroviruses, 1993-10, Vol.9 (10), p.985-996

1993

Volltextzugriff (PDF)

Biochemical characterization of cell-associated and extracellular products of the friend spleen focus-forming virus env gene

Virology (New York, N.Y.), 1989-11, Vol.173 (1), p.136-143

1989

Volltextzugriff (PDF)

Reinterpretation of human immunodeficiency virus western blot patterns

The New England journal of medicine, 1989-05, Vol.320 (19), p.1280

1989

Volltextzugriff (PDF)

Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of friend mink cell focus-inducing murine leukemia virus envelope proteins

Virology (New York, N.Y.), 1984-07, Vol.136 (1), p.196-210

1984

Volltextzugriff (PDF)

Comparison of structural domains of gp70s of ecotropic Akv and dualtropic MCF-247 MuLVs

Virology (New York, N.Y.), 1983-01, Vol.129 (1), p.40-50

1983

Volltextzugriff (PDF)

Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies

Virology (New York, N.Y.), 1982-01, Vol.116 (2), p.499-516

1982

Volltextzugriff (PDF)

Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination

Journal of immunological methods, 2021-12, Vol.499, p.113165-113165, Article 113165

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection

Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

Characterization of Structural Features and Diversity of Variable-Region Determinants of Related Quaternary Epitopes Recognized by Human and Rhesus Macaque Monoclonal Antibodies Possessing Unusually Potent Neutralizing Activities

Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activity Is Usually Restricted by Epitope Masking

Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study

Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry

The C108g Epitope in the V2 Domain of gp120 Functions as a Potent Neutralization Target When Introduced into Envelope Proteins Derived from Human Immunodeficiency Virus Type 1 Primary Isolates

Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes

Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci

V3-Specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1

Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site

Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120

A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody

A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates

Biochemical characterization of cell-associated and extracellular products of the friend spleen focus-forming virus env gene

Reinterpretation of human immunodeficiency virus western blot patterns

Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of friend mink cell focus-inducing murine leukemia virus envelope proteins

Comparison of structural domains of gp70s of ecotropic Akv and dualtropic MCF-247 MuLVs

Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies

Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination

Suchergebnisse filtern